Navigation Links
Portugal Pharmaceuticals and Healthcare Report Q3 2014
Date:7/28/2014

NEW YORK, July 28, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Portugal Pharmaceuticals and Healthcare Report Q3 2014

http://www.reportlinker.com/p0207141/Portugal-Pharmaceuticals-and-Healthcare-Report-Q3-2014.html

Includes 3 FREE quarterly updates

BMI View:
Faster-than-expected economic growth last quarter has led us to revise our healthcare and
pharmaceutical forecasts slightly upwards. As forecast previously, BMI expects Portugal's healthcare market to return to growth in 2015, while pharmaceuticals will not return to growth until 2019. This is because while Portugal exited its bailout programme in May 2014 without the need for a new financial package, government austerity measures are likely to curb pharmaceutical reimbursement. Portuguese public hospitals are unable to reduce their deficits, constraining any rises in per capita spending. The shortage of healthcare professionals has left hospitals understaffed, as the emigration of young Portuguese is exacerbating the healthcare burden. We forecast that Portugal's healthcare market will return to growth in 2015, while pharmaceuticals will only return to growth in 2019.

Headline Expenditure Projections

- Pharmaceuticals: EUR3.48bn (USD4.59bn) in 2013 to EUR3.28bn (USD4.40); -5.6% in local currency and -4.2% in US dollar terms. Forecast revised upwards from Q214.
- Healthcare: EUR15.10bn (USD19.93bn) in 2013 to EUR15.08bn (USD20.21bn) in 2014; -0.1% in local currency and +1.4% in US dollar terms. Forecast revised upwards from Q214.
BMI Industry View 7
SWOT .. 9
Political 11
Economic . 12
Business Environment 13
Industry Forecast .. 14
Pharmaceutical Market Forecast . 14
Table: Pharmaceutical Sales, Historical Data And Forecasts (Portugal 2010-2018) . . 17
Healthcare Market Forecast . 18
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Portugal 2010-2018) 21
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts . . 21
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts . 22
Prescription Drug Market Forecast 23
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Portugal 2010-2018) . 25
Patented Drug Market Forecast .. 26
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Portugal 2010-2018) . 29
Generic Drug Market Forecast 30
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Portugal 2010-2018) . . 33
Table: Top Generic Drugs By Value In 2011 . 33
Table: Average Price Of Top Generic Drugs By Value 2010-2011 . . 34
OTC Medicine Market Forecast .. 35
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Portugal 2010-2018) 37
Table: OTC Sales Outside Of Pharmacies By Therapeutic Group (Jan-Sep 2012) . 37
Table: OTC Sales Outside Of Pharmacies By District (Jan-Sep 2012) . . 38
Table: OTC Sales Outside Of Pharmacies By Sales Outlet (Jan-Sep2012) 38
Table: Portugal OTC Sales Outside Of Pharmacies By Active Ingredient (Jan-Sep 2012) . . 39
Pharmaceutical Trade Forecast .. 40
Table: Pharmaceutical Trade Data And Forecasts (Portugal 2012-2018) . 43
Table: Pharmaceutical Trade Data And Forecasts local currency (Portugal 2012-2018) 43
Other Healthcare Data .. 44
Key Risks To BMI's Forecast Scenario 45
Macroeconomic Forecasts .. 46
Economic Analysis . 46
Industry Risk Reward Ratings 51
Western Europe Risk/Reward Ratings . 51
Portugal Risk/Reward Ratings . 56
Rewards . 56
Risks 57
Market Overview 58
Industry Trends And Developments .. 60
Epidemiology 60
Healthcare System 63
Hospital Infrastructure And Services . 64
Outpatient Infrastructure And Services . 65
Healthcare Workforce .. 66
Clinical Trials .. 67
Regulatory Development .. 69
Regulatory Regime .. 69
Parallel Imports 71
Recent EU Regulatory Developments 75
Pricing Regime . 76
Reimbursement Regime 80
Pharmacoeconomics . 81
Competitive Landscape . 83
Pharmaceutical Sector . 83
Pharmaceutical Distribution .. 87
Pharmaceutical Retail Sector . 87
Table: Number Of Pharmaceutical Companies, Wholesalers, Pharmacies, Pharmacy Extensions And Drug Stores In Portugal . 90
Company Profile . 91
Hovione 91
Bial 95
Medinfar 100
Bluepharma .. 103
Demographic Forecast 106
Table: Portugal's Population By Age Group, 1990-2020 ('000) . . 107
Table: Portugal's Population By Age Group, 1990-2020 (% of total) . . 108
Table: Portugal's Key Population Ratios, 1990-2020 109
Table: Portugal's Rural And Urban Population, 1990-2020 109
Glossary 110
Methodology .. 112
Pharmaceutical Expenditure Forecast Model .. 112
Healthcare Expenditure Forecast Model 112
Notes On Methodology .. 113
Risk/Reward Ratings Methodology . 114
Ratings Overview .. 115
Table: Pharmaceutical Risk/Reward Ratings Indicators . 115
Indicator Weightings . 116

To order this report: Portugal Pharmaceuticals and Healthcare Report Q3 2014
http://www.reportlinker.com/p0207141/Portugal-Pharmaceuticals-and-Healthcare-Report-Q3-2014.html

_________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001


'/>"/>
SOURCE Reportlinker
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
2. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Icahn Issues Statement Regarding Amylin Pharmaceuticals
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... Feb 27, 2017 Period October – December 2016 ... Operating result amounted to SEK -16.4 (-6.4) million Result after ... (-0.22) before and after dilution Cash flow from operating activities ... ... 0.4 (0.4) million Operating result amounted to SEK -39.5 (-29.5) ...
(Date:2/24/2017)... , Feb. 24, 2017 Research and ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... a CAGR of around 23.8% over the next decade to reach ... the market estimates and forecasts for all the given segments on ...
(Date:2/24/2017)... 24, 2017 Research and Markets has announced the ... 2016" report to their offering. ... The latest research Dry eye Drugs Price Analysis and Strategies ... eye market. The research answers the following questions: ... their clinical attributes? How are they positioned in the Global Dry eye ...
Breaking Medicine Technology:
(Date:2/26/2017)... ... 26, 2017 , ... Today, A' Design Awards & Competition ... Social Design Awards. , The 7th A' Social Design Award is open ... worldwide with realized projects and conceptual works. , The first phase of the ...
(Date:2/26/2017)... , ... February 26, 2017 ... ... a new technology standard in staffing, scheduling, and reporting for healthcare organizations. ... predict activity throughout the entire staffing process. StaffBridge technology improves staffing efficiency, ...
(Date:2/24/2017)... , ... February 24, 2017 , ... ... newly designed TaskMate Go. Core benefits and advantages built into the home office ... stylish, functional look and feel. Ability to gain the benefits embedded in the ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... Liberty University, has officially announced the appointment of Peter A. Bell, DO, MBA, ... Osteopathic Medicine (LUCOM), beginning April 10. Dr. Bell comes to Liberty from ...
(Date:2/24/2017)... ... 2017 , ... The narrative in “ Signal 8: An Australian Paramedic’s Story ... his paramedic experiences. Schanssema describes the tragedies he saw, as well as his struggles ... , Schanssema, initially unsure of the career path he wanted to take, found fulfillment ...
Breaking Medicine News(10 mins):